Literature DB >> 25181010

The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Takeki Uehara1, Igor P Pogribny, Ivan Rusyn.   

Abstract

Human hepatocellular carcinoma (HCC) develops most often as a complication of fibrosis or cirrhosis. While most human studies of HCC provide crucial insights into the molecular signatures of HCC, seldom do they address the etiology of HCC. Mouse models are essential tools for investigating the pathogenesis of HCC; however, the overwhelming majority of cancer models in rodents do not feature liver fibrosis. Detailed in this unit is a protocol for an experimental mouse model of HCC that arises in association with advanced liver fibrosis. The disease model is induced by a single injection of N-nitrosodiethylamine (DEN) followed by repeated administration of carbon tetrachloride (CCl4 ). A dramatic potentiation of liver tumor incidence is observed following administration of DEN and CCl4 , with 100% of mice developing liver tumors at 5 months of age. This model can be employed for studying the molecular mechanisms of fibrogenesis and HCC development, and in cancer hazard/chemotherapy testing of drug candidates.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  cancer; fibrosis; genotoxic; liver; mechanisms

Mesh:

Substances:

Year:  2014        PMID: 25181010      PMCID: PMC4214366          DOI: 10.1002/0471141755.ph1430s66

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  36 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Mouse models of hepatocellular carcinoma.

Authors:  Nelson Fausto; Jean S Campbell
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 3.  Hepatocellular carcinoma pathogenesis: from genes to environment.

Authors:  Paraskevi A Farazi; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

4.  The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.

Authors:  Monique Y Wells; E Spencer Williams
Journal:  Regul Toxicol Pharmacol       Date:  2008-12-25       Impact factor: 3.271

5.  Molecular classification of hepatocellular carcinoma.

Authors:  Jessica Zucman-Rossi
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

6.  Ultrasonographic evidence of phenotypic instability during hepatocarcinogenesis in N-nitrosomorpholine-treated rats.

Authors:  Jong-Young Oh; Jin-Sook Jeong; Yu-jin Kim; Kyoung-Jin Nam; Byung-Ho Park; Eun-Young Kwon; Young-Hoon Kim; Tae-Ho Hwang
Journal:  Exp Mol Pathol       Date:  2002-08       Impact factor: 3.362

7.  Cancer risk assessment approaches at the FDA/CDER: Is the era of the 2-year bioassay drawing to a close?

Authors:  David Jacobson-Kram
Journal:  Toxicol Pathol       Date:  2009-11-03       Impact factor: 1.902

Review 8.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

9.  Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends.

Authors:  Peter Jepsen; Hendrik Vilstrup; Robert E Tarone; Søren Friis; Henrik Toft Sørensen
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

Review 10.  A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer.

Authors:  Mark J Hoenerhoff; Hue Hua Hong; Tai-vu Ton; Stephanie A Lahousse; Robert C Sills
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

View more
  43 in total

1.  Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.

Authors:  Shinji Furuya; Joseph A Cichocki; Kranti Konganti; Kostiantyn Dreval; Takeki Uehara; Yuuki Katou; Hisataka Fukushima; Hiroshi Kono; Igor P Pogribny; Josepmaria Argemi; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

2.  Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.

Authors:  Alejandro Torres-Hernandez; Wei Wang; Yuri Nikiforov; Karla Tejada; Luisana Torres; Aleksandr Kalabin; Yue Wu; Muhammad Israr Ul Haq; Mohammed Y Khan; Zhen Zhao; Wenyu Su; Jimmy Camargo; Mautin Hundeyin; Brian Diskin; Salma Adam; Juan A Kochen Rossi; Emma Kurz; Berk Aykut; Sorin A A Shadaloey; Joshua Leinwand; George Miller
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

3.  Hepatocyte Wnts Are Dispensable During Diethylnitrosamine and Carbon Tetrachloride-Induced Injury and Hepatocellular Cancer.

Authors:  Morgan Preziosi; Minakshi Poddar; Sucha Singh; Satdarshan P Monga
Journal:  Gene Expr       Date:  2018-03-08

4.  A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.

Authors:  Shinji Furuya; Grace A Chappell; Yasuhiro Iwata; Takeki Uehara; Yuki Kato; Hiroshi Kono; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-15       Impact factor: 4.219

5.  Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models.

Authors:  Robert Allen Kaiser; Clara Teresa Nicolas; Kari Lynn Allen; Jennifer Anne Chilton; Zeji Du; Raymond Daniel Hickey; Joseph Benjamin Lillegard
Journal:  Hum Gene Ther Clin Dev       Date:  2019-04-11       Impact factor: 5.032

6.  Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.

Authors:  Yong-Fang Ding; Zhen-Hui Wu; Ying-Jie Wei; Luan Shu; Yun-Ru Peng
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-25       Impact factor: 4.553

Review 7.  Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.

Authors:  Michael Karin; Debanjan Dhar
Journal:  Carcinogenesis       Date:  2016-05-04       Impact factor: 4.944

8.  Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis.

Authors:  Aline de Conti; Volodymyr Tryndyak; Renato Heidor; Leandro Jimenez; Fernando Salvador Moreno; Frederick A Beland; Ivan Rusyn; Igor P Pogribny
Journal:  J Nutr Biochem       Date:  2020-09-11       Impact factor: 6.048

9.  HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2.

Authors:  Vladimir Pecenka; Petr Pajer; Vít Karafiat; Petra Kasparova; Jana Dudlova; Michal Dvorak
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

10.  Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.

Authors:  Takashi Kato; Daisuke Murata; Robert A Anders; Hiromi Sesaki; Miho Iijima
Journal:  Biochem Biophys Res Commun       Date:  2021-03-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.